Video Shorts

0:59
Solving the Diagnostic Gap in AL Amyloidosis
3 months ago
by
Joselle Cook, MD

1:10
What Do You Wish Every Dermatology Resident Knew Before Graduation?
3 months ago
by
Susan Taylor, MD(+2 more)

1:10
Big Change: Zepbound Now Available in Multi-Dose KwikPen
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:41
New Guidelines Shift Hereditary Angioedema Treatment Strategy
3 months ago
by
Mauro Cancian, MD, PhD

1:14
How AI Bias in Dermatology Affects Patients of Color
3 months ago
by
Mona Shahriari, MD, FAAD(+2 more)

0:42
What Actually Stops Living Kidney Donors
3 months ago
by
Mary K Roberts, PhD

1:07
New High-Dose Semaglutide: The Future of Weight Loss?
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:03
Why Clear Skin Isn’t Enough for Success in Psoriasis
3 months ago
by
Ronald Vender, MD

1:10
A 1-Year Implantable CGM? The Future of Diabetes Tech is Here
3 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:01
The Challenge of Concentrated Insulin and Micro-Dosing
4 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:59
Early Gut Bacteria Suppress Allergen-Specific IgE Without Affecting IgG
4 months ago
by
Susanne Brix Pedersen

1:18
Single-Dose COMP360 Psilocybin Shows Clinical Benefit in Phase 3 TRD Trial
4 months ago
by
Steve Levine, MD

0:59
The Flaw in Heart Diagnostics: Diameters Versus Volumes
4 months ago
by
Nina Ajmone Marsan, MD(+1 more)

1:24
Durable Real-World Attack Reduction Across HAE Types at 18 Months
4 months ago
by
Raffi Tachdjian, MD, MPH

1:08
Warning Signs on Your Nails for Skin Cancer Detection
4 months ago
by
Ashfaq Marghoob, MD

0:39
A Medical First: Kidney Transplant Without Daily Pills
4 months ago
by
Allan Kirk, MD, PhD

1:12
Oral Ozempic & Wegovy: The Future of Weight Loss Treatment
4 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:19
Why Underserved Patient Stories Matter in Dermatology
4 months ago
by
Abrahem Kazemi, MD

0:46
Early Antibiotics Linked to 30% Allergy Rate in Childhood
4 months ago
by
Moath Hattab, MD

1:06
The Hidden Dangers of Compounded Oral Ozempic
4 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:13
Novo Nordisk Sues Over Unspecified Oral GLP-1 Formulation
4 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:59
Lung Cancer Risk Score with New Calculator Does Not Equal A Diagnosis
4 months ago
by
Jessica Moffatt, PhD

1:16
An AI Revolution in Interventional Cardiology?
4 months ago
by
David Rizik, MD(+1 more)

1:07
Tips on Spotting Early Melanoma on the Face
4 months ago
by
Ashfaq Marghoob, MD

0:43
How Temperature Extremes Impact Vaso-Occlusive Crisis Risks
4 months ago
by
Frank Gonzalez, MD

1:29
Updated Anaphylaxis Guidelines: What Clinicians Need to Know
4 months ago
by
David Golden, MD(+1 more)

1:03
Food Industry Issues And Fixing Dietary Habits
4 months ago
by
Nancy Reau, MD(+3 more)

0:58
Cuffless Wearables in Hypertension Monitoring
4 months ago
by
Adam Bress, PharmD, MS

0:43
GLP-1 Drugs: More Than Just Weight Loss
4 months ago
by
Vlado Perkovic, MBBS, PhD

0:47
Why Oncodermatology is More Critical Than Ever
4 months ago
by
Drew Kuraitis, MD, PhD
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
3
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
4
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
5
